Improving Antibiotic Prescribing for Urinary Tract Infections in Frail Elderly
ImpresU-WP2
The Improving Rational Prescribing for Urinary Tract Infections in Frail Elderly (ImpresU) Project - Work Package 2 (WP2): a Cluster Randomised Multifaceted Antibiotic Stewardship Intervention Study
6 other identifiers
interventional
1,146
4 countries
4
Brief Summary
The purpose of this study is to determine whether a tailored multifaceted antibiotic stewardship intervention reduces antibiotic use for urinary tract infections in residential care homes and nursing homes attended by general practitioners. This will be evaluated in a pragmatic cluster randomised controlled trial using a modified community-based participatory action research approach.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2019
Typical duration for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 26, 2019
CompletedFirst Posted
Study publicly available on registry
May 31, 2019
CompletedStudy Start
First participant enrolled
September 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 21, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
July 21, 2021
CompletedMay 24, 2022
May 1, 2022
1.9 years
May 26, 2019
May 23, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
UTI prescriptions
Number of prescriptions of antibiotics for suspected urinary tract infections expressed per patient-year
Assessed during the 7-month follow-up period
Secondary Outcomes (8)
Incorrect UTI prescriptions
Assessed during the 7-month follow-up period
UTI suspicions
Assessed during the 7-month follow-up period
Complications
Assessed during the 7-month follow-up period
Hospital referral
Assessed during the 7-month follow-up period
Hospital admission
Assessed during the 7-month follow-up period
- +3 more secondary outcomes
Study Arms (2)
intervention
EXPERIMENTALThe antibiotic stewardship intervention will encourage to prescribe according to the latest relevant UTI guidelines which promote more restrictive use of antibiotics in case of non-specific symptoms.
control
NO INTERVENTIONUsual care
Interventions
The intervention is multifaceted, consisting of the implementation of an algorithm for restrictive use of antibiotics as proposed in recent guidelines (Verenso, Dutch guideline), tailored in close collaboration with local stakeholders to the specific implementation setting, by means of a modified participatory-action research (PAR) approach. To support the process of intervention-tailoring and -implementation, a toolbox comprising of materials, aids and actions is developed to be used at the discretion of the local stakeholders to support implementation of the algorithm.The algorithm is congruent with the Swedish and Norwegian guidelines, which also promote more restrictive use of antibiotics in case of non-specific symptoms, even though the algorithm is more detailed.
Eligibility Criteria
You may qualify if:
- physical and/or mental disabilities and ADL dependency requiring residential care or nursing home care
- attended by general practitioners
- not on continuous prophylactic antibiotic use
You may not qualify if:
- in hospice-care
- very limited life expectancy (≤1 month)
- no longer wish to participate
- start continuous antibiotic (prophylaxis)
- die or move away from the residential care home / nursing home
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cees Hertoghlead
- UMC Utrechtcollaborator
- Medical University of Lodzcollaborator
- University of Oslocollaborator
- Vastra Gotaland Regioncollaborator
- Göteborg Universitycollaborator
Study Sites (4)
University Medical Center Utrecht
Utrecht, 3584 CG, Netherlands
University of Oslo
Oslo, 1130, Norway
Medical University of Lodz
Lodz, 90-153, Poland
Research and Development Primary Health Care, Region Västra Götaland
Borås, SE-503 38, Sweden
Related Publications (3)
Hartman EAR, Groen WG, Heltveit-Olsen SR, Lindbaek M, Hoye S, Lithen SS, Sundvall PD, Sundvall S, Snaebjornsson Arnljots E, Gunnarsson R, Kowalczyk A, Godycki-Cwirko M, van de Pol AC, Platteel TN, Monnier AA, Verheij TJM, Hertogh CMPM. Implementation of a tailored multifaceted antibiotic stewardship intervention to improve antibiotic prescribing for urinary tract infections in frail older adults (ImpresU) in four European countries: a process evaluation alongside a pragmatic cluster randomized controlled trial. Trials. 2024 Oct 18;25(1):691. doi: 10.1186/s13063-024-08545-4.
PMID: 39425170DERIVEDHartman EAR, van de Pol AC, Heltveit-Olsen SR, Lindbaek M, Hoye S, Lithen SS, Sundvall PD, Sundvall S, Arnljots ES, Gunnarsson R, Kowalczyk A, Godycki-Cwirko M, Platteel TN, Groen WG, Monnier AA, Zuithoff NP, Verheij TJM, Hertogh CMPM. Effect of a multifaceted antibiotic stewardship intervention to improve antibiotic prescribing for suspected urinary tract infections in frail older adults (ImpresU): pragmatic cluster randomised controlled trial in four European countries. BMJ. 2023 Feb 22;380:e072319. doi: 10.1136/bmj-2022-072319.
PMID: 36813284DERIVEDHartman EAR, Groen WG, Heltveit-Olsen SR, Lindbaek M, Hoye S, Sundvall PD, Gunnarsson R, Skoglund I, Snaebjornsson Arnljots E, Godycki-Cwirko M, Kowalczyk A, Platteel TN, Zuithoff NPA, Monnier AA, Verheij TJM, Hertogh CMPM, van de Pol AC. Multifaceted antibiotic stewardship intervention using a participatory-action-research approach to improve antibiotic prescribing for urinary tract infections in frail elderly (ImpresU): study protocol for a European qualitative study followed by a pragmatic cluster randomised controlled trial. BMJ Open. 2021 Oct 7;11(10):e052552. doi: 10.1136/bmjopen-2021-052552.
PMID: 34620666DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Cees MP Hertogh, prof. dr.
Amsterdam UMC, location VUmc
- PRINCIPAL INVESTIGATOR
Theo JM Verheij, prof. dr.
UMC Utrecht
- PRINCIPAL INVESTIGATOR
Maciek Godycki-Cwirko, prof.dr.
Medical University of Lodz
- PRINCIPAL INVESTIGATOR
Morten Lindbæk, prof. dr.
University of Oslo
- PRINCIPAL INVESTIGATOR
Pär-Daniel Sundvall, MD PhD
Göteborg University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Prof. dr.
Study Record Dates
First Submitted
May 26, 2019
First Posted
May 31, 2019
Study Start
September 1, 2019
Primary Completion
July 21, 2021
Study Completion
July 21, 2021
Last Updated
May 24, 2022
Record last verified: 2022-05
Data Sharing
- IPD Sharing
- Will not share